Deoxycytidine triphosphate-15N3 (dilithium)

CAT:
804-HY-101400S3
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Deoxycytidine triphosphate-15N3 (dilithium) - image 1

Deoxycytidine triphosphate-15N3 (dilithium)

  • UNSPSC Description:

    Deoxycytidine triphosphate-15N3 (dCTP-15N3 dilithium; 2′-Deoxycytidine-5′-triphosphate-15N3) dilithium is 15N labeled Deoxycytidine triphosphate (HY-101400). Deoxycytidine triphosphate (dCTP) is a nucleoside triphosphate that can be used for DNA synthesis. Deoxycytidine triphosphate has many applications, such as real-time PCR, cDNA synthesis, and DNA sequencing.
  • Target Antigen:

    DNA/RNA Synthesis; Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/Analog
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;Others
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/deoxycytidine-triphosphate-15n3-dilithium.html
  • Purity:

    99.0
  • Solubility:

    10 mM in DMSO
  • Smiles:

    O[C@H]1C[C@H]([15N]2C([15N]=C([15NH2])C=C2)=O)O[C@@H]1COP(OP(OP(O)(O[Li])=O)(O[Li])=O)(O)=O
  • Molecular Weight:

    482.00
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]M H Tattersall, et al. Deoxyribonucleoside triphosphates in human cells: changes in disease and following exposure to drugs. Eur J Clin Invest. 1975 Apr;5(2):191-202.|[3]A W Harris, et al. Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1979 Feb;39(2 Pt 1):538-41.|[4]B A Bladergroen, et al. CTP:phosphoethanolamine cytidylyltransferase. Biochim Biophys Acta. 1997 Sep 4;1348(1-2):91-9.
  • Shipping Conditions:

    Blue Ice
  • Storage Conditions:

    Solution, -20°C, 2 years
  • Clinical Information:

    No Development Reported